RecallDepth
Class III Terminated

RIVASTIGMINE Tartrate Capsules, USP, 1.5 mg, 60-count bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally 500-900 India, NDC 55111-352-60

This recall has been terminated (originally issued April 12, 2017).

Company
Dr. Reddy'S Laboratories, Inc.
Recall Initiated
March 6, 2017
Posted
April 12, 2017
Recall Number
D-0649-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,728 bottles
Firm Location
Princeton, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Cross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine.

Distribution

U.S. nationwide

Lot / Code Info

Lot #C607323, Exp 10/18

More recalls by Dr. Reddy'S Laboratories, Inc.

View all recalls by this company →

Other recent Class III Drug recalls